These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10330857)

  • 21. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and risk factors for MRSA in adult emergency admissions: a case for screening all patients?
    Guleri A; Sharma R; Smith GW
    J Hosp Infect; 2007 Sep; 67(1):96-7. PubMed ID: 17719680
    [No Abstract]   [Full Text] [Related]  

  • 23. Resistance in the intensive care unit: whose problem is it and how can intensivists help?
    Shorr AF; Lipman J
    Crit Care Med; 2007 Jan; 35(1):299-301. PubMed ID: 17197773
    [No Abstract]   [Full Text] [Related]  

  • 24. [Big differences when it comes to antibiotic resistance between European intensive care units].
    Hanberger H
    Lakartidningen; 2001 Oct; 98(44):4827-8. PubMed ID: 11729794
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fighting MRSA in hospitals: time to restrict the broad use of specific antimicrobial classes?
    Monnet DL; MacKenzie FM; Skov R; Jensen ET; Gould IM; Frimodt-Møller N
    J Hosp Infect; 2005 Nov; 61(3):267-8. PubMed ID: 16009460
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antibiotics in a hospital hygienic perspective].
    Frimodt-Møller N; Gahrn-Hansen B
    Ugeskr Laeger; 2007 Dec; 169(49):4254-6. PubMed ID: 18208702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multiresistant bacteria bigger and bigger threat in Swedish ICU. Quality assurance of hygiene routines and registration of complications are needed].
    Walther SM; Agvald-Ohman C; Blomqvist H; Monnet DL; Nilsson LE; Hanberger H
    Lakartidningen; 2006 Dec 6-12; 103(49):3930-3. PubMed ID: 17212272
    [No Abstract]   [Full Text] [Related]  

  • 29. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an Intensive Care Unit.
    Gould IM; MacKenzie FM; MacLennan G; Pacitti D; Watson EJ; Noble DW
    Int J Antimicrob Agents; 2007 May; 29(5):536-43. PubMed ID: 17337163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey.
    Vriens M; Blok H; Fluit A; Troelstra A; Van Der Werken C; Verhoef J
    Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):782-6. PubMed ID: 12461587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The bacteria fight back.
    Taubes G
    Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bacterial hospitalism in the light of current knowledge on the origin and mechanism of antibiotic resistance].
    Lebek G
    Med Monatsschr; 1970 Apr; 24(4):142-5. PubMed ID: 5485956
    [No Abstract]   [Full Text] [Related]  

  • 33. [Reasonable hospital use of mupirocin].
    Lucet J; Descamps V
    Ann Dermatol Venereol; 2000 Apr; 127(4):365-6. PubMed ID: 10844254
    [No Abstract]   [Full Text] [Related]  

  • 34. Fighting today's superbugs infection control at the forefront.
    Dragon N
    Aust Nurs J; 2006 Aug; 14(2):16-9. PubMed ID: 16925050
    [No Abstract]   [Full Text] [Related]  

  • 35. [New Strama-work in Ostergotland. The LIRA-concept gives best results].
    Hanberger H; Dannetun E; Rutberg H
    Lakartidningen; 2007 Nov 7-13; 104(45):3351-2. PubMed ID: 18062634
    [No Abstract]   [Full Text] [Related]  

  • 36. MRSA: an evolving pathogen.
    Corriere MD; Decker CF
    Dis Mon; 2008 Dec; 54(12):751-5. PubMed ID: 18996275
    [No Abstract]   [Full Text] [Related]  

  • 37. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.
    Henderson DK
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S46-54: discussion S64-73. PubMed ID: 16813982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inadequate hygiene costs Swedish health care half a billion per year. Interview by Maria Ejd].
    Fryklund B
    Vardfacket; 1992 May; 16(1O):6. PubMed ID: 1292269
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nosocomial bacteria: profiles of resistance].
    Sow AI
    Dakar Med; 2005; 50(1):7-9. PubMed ID: 16190117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility patterns of staphylococci in a tertiary care hospital.
    Dhawan B; Mohanty S; Das BK; Kapil A
    Natl Med J India; 2004; 17(1):52-3. PubMed ID: 15115236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.